Browse
Prediction results retrieved after performance evaluation of WHO approved 34 primers to estimate their binding affinities for 3892 SARS-CoV-2 variants.

Lineage
(WHO label)
  
Target Gene
  
Primer Name
  
Primer Sequence
  
Primer Length
  
Primer GC Content (%)
  
Start Position
  
End Position
  
Primer Direction
  
ΔG (cal)
  
Primer first used
  
B.34NUS-CDC-N-2GCGCGACATTCCGAAGAA1855.562923029213R-21404.2US
B.34NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
B.34NChan-NGCGTTCTTCGGAATGTCG1855.562921029227F-21207.6China
B.1.248NUS-CDC-N-2GCGCGACATTCCGAAGAA1855.562923029213R-21404.2US
B.1.248NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
B.1.248NChan-NGCGTTCTTCGGAATGTCG1855.562921029227F-21207.6China
B.32NUS-CDC-N-2GCGCGACATTCCGAAGAA1855.562923029213R-21404.2US
B.32NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
B.32NChan-NGCGTTCTTCGGAATGTCG1855.562921029227F-21207.6China
B.1.70NUS-CDC-N-2GCGCGACATTCCGAAGAA1855.562923029213R-21404.2US
B.1.70NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
B.1.70NChan-NGCGTTCTTCGGAATGTCG1855.562921029227F-21207.6China
B.1.1.43NUS-CDC-N-2GCGCGACATTCCGAAGAA1855.562923029213R-21404.2US
B.1.1.43NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
B.1.1.43NChan-NGCGTTCTTCGGAATGTCG1855.562921029227F-21207.6China
B.1.559NUS-CDC-N-2GCGCGACATTCCGAAGAA1855.562923029213R-21404.2US
B.1.559NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
B.1.559NChan-NGCGTTCTTCGGAATGTCG1855.562921029227F-21207.6China
B.1.1.14NUS-CDC-N-2GCGCGACATTCCGAAGAA1855.562923029213R-21404.2US
B.1.1.14NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
B.1.1.14NChan-NGCGTTCTTCGGAATGTCG1855.562921029227F-21207.6China
B.1.1.406NUS-CDC-N-2GCGCGACATTCCGAAGAA1855.562923029213R-21404.2US
B.1.1.406NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
B.1.1.406NChan-NGCGTTCTTCGGAATGTCG1855.562921029227F-21207.6China
B.1.69NUS-CDC-N-2GCGCGACATTCCGAAGAA1855.562923029213R-21404.2US
B.1.69NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
B.1.69NChan-NGCGTTCTTCGGAATGTCG1855.562921029227F-21207.6China
A.26NUS-CDC-N-2GCGCGACATTCCGAAGAA1855.562923029213R-21404.2US
A.26NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
A.26NChan-NGCGTTCTTCGGAATGTCG1855.562921029227F-21207.6China
ER.1.1NUS-CDC-N-2GCGCGACATTCCGAAGAA1855.562923029213R-21404.2US
ER.1.1NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
ER.1.1NChan-NGCGTTCTTCGGAATGTCG1855.562921029227F-21207.6China
CH.1.1.23NUS-CDC-N-2GCGCGACATTCCGAAGAA1855.562923029213R-21404.2US
CH.1.1.23NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
CH.1.1.23NChan-NGCGTTCTTCGGAATGTCG1855.562921029227F-21207.6China
B.1.640NUS-CDC-N-2GCGCGACATTCCGAAGAA1855.562923029213R-21404.2US
B.1.640NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
B.1.640NChan-NGCGTTCTTCGGAATGTCG1855.562921029227F-21207.6China
BA.1.1.9NUS-CDC-N-2GCGCGACATTCCGAAGAA1855.562923029213R-21404.2US
BA.1.1.9NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
BA.1.1.9NChan-NGCGTTCTTCGGAATGTCG1855.562921029227F-21207.6China
BA.1.1.3NUS-CDC-N-2GCGCGACATTCCGAAGAA1855.562923029213R-11828.8US
BA.1.1.3NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
BA.1.1.3NChan-NGCGTTCTTCGGAATGTCG1855.562921029227F-15161.9China
AY.43.6 (Delta)NUS-CDC-N-2GCGCGACATTCCGAAGAA1855.562923029213R-21404.2US
AY.43.6 (Delta)NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
AY.43.6 (Delta)NChan-NGCGTTCTTCGGAATGTCG1855.562921029227F-21207.6China
XBF.4NUS-CDC-N-2GCGCGACATTCCGAAGAA1855.562923029213R-21404.2US
XBF.4NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
Lineage
(WHO label)
  
Target Gene
  
Primer Name
  
Primer Sequence
  
Primer Length
  
Primer GC Content (%)
  
Start Position
  
End Position
  
Primer Direction
  
ΔG (cal)
  
Primer first used